Flore by Sun Genomics
San Diego
About Flore by Sun Genomics
Sun Genomics is a precision nutrition company focused on curing dysbiosis through the gut microflora and personalized solutions. Its flagship product Floré, is a microbiome test and custom synbiotics solution that utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completely personalized product based on their unique gut profiles. The company also offers: Floré Tots, Kids, and Baby, available for kids up to age 0-12, and comes in an easy digestive powder to mix with their favorite drink. Floré Clinical, which is specifically for professional practitioners and their patients. Floré Defense, Balance, and Performance for sports teams and athletes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.2M
- Funding stage: Early Stage Venture
- Last round: Convertible Note (Nov 2024)
- Website: flore.com
- Phone: 661-888-4799
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Medical, Nutrition
Social Profiles
Canonical: https://fsome.com/organization/flore-by-sun-genomics-95457 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.